Condition: Postpartum Hemorrhage · Sponsor: University Hospital, Bordeaux
The aim is to assess the impact of tranexamic acid (TXA) for preventing postpartum hemorrhage (PPH) following a cesarean section (CS).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| CHU Angers | Angers, France | — |
| CHU Jean Minjoz | Besançon, France | — |
| CHU Bordeaux | Bordeaux, France | — |
| CHRU Côte de Nacre | Caen, France | — |
| CHU Estain | Clermont-Ferrand, France | — |
| Centre Hospitalier Intercommunal de Créteil | Créteil, France | — |
| Hôpital Saint Joseph Marseille | Marseille, France | — |
| Hopital Nord | Marseille, France | — |
| CHU de Montpellier | Montpellier, France | — |
| CHRU de Nancy | Nancy, France | — |
| CHU Nantes | Nantes, France | — |
| CHU Nîmes | Nîmes, France | — |
+ 14 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.